AVBP Competitors & Alternatives
Compare ArriVent BioPharma, Inc. Common Stock with similar stocks in the same industry
Biotechnology
AVBP
Main Stock$30.16
Tradestie Score
61
Market Cap
$748.90M
Analyst Upside
+39.6%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.89
|
$1.50B | 7.4 | 61 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$42.88
|
$1.50B | - | 53 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$15.22
|
$1.49B | - | 62 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$23.96
|
$1.43B | - | 51 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$13.78
|
$1.42B | - | 55 | Compare |
|
MPLT
MPLT
|
$27.35
|
$1.38B | - | 55 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$18.33
|
$1.35B | - | 56 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.18
|
$1.32B | - | 61 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$6.86
|
$1.29B | 99.0 | 65 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.82
|
$1.29B | - | 58 | Compare |
More AVBP Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry